Emerging Sub-Segments Transforming the Bioprocessing Technology Market Landscape

The bioprocessing technology market is poised for significant expansion in the coming years as advancements in biomanufacturing continue to accelerate. Driven by growing demand for biopharmaceuticals and innovative process improvements, this sector is attracting considerable attention from industry leaders and investors alike. Let's delve into the current market valuation, key players, emerging trends, and the product and application segments shaping this dynamic field.

Expected Market Growth and Size of the Bioprocessing Technology Market
The bioprocessing technology market is forecasted to surge to a valuation of $139.77 billion by 2030, growing at an impressive compound annual growth rate (CAGR) of 14.5%. This growth is propelled by a variety of factors including rising demand for biosimilars and recombinant proteins, increased adoption of automation in biomanufacturing processes, expansion in the production of personalized medicines, heightened emphasis on process optimization, and growing outsourcing to contract manufacturing organizations (CMOs). Key trends anticipated during this period include the widespread adoption of single-use bioprocessing systems, growing utilization of automated cell expansion platforms, integration of advanced biologics safety testing, development of continuous bioprocessing techniques, and a stronger focus on scalable biomanufacturing solutions.

Download a free sample of the bioprocessing technology market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10540&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Feb_PR

Driving Forces Behind the Bioprocessing Technology Market Expansion
One of the main drivers for the bioprocessing technology market is the escalating need for biosimilars and recombinant proteins, which are crucial components of modern therapeutics. This demand compels manufacturers to invest heavily in advanced bioprocessing technologies that can improve yield and efficiency.
Additionally, automation is becoming increasingly prevalent in biomanufacturing. By streamlining processes and reducing human error, automation enhances productivity and consistency, making it an essential factor in the market's rapid growth.

Key Players Leading the Bioprocessing Technology Industry
Several prominent companies dominate the bioprocessing technology market, including Thermo Fisher Scientific Inc., Sartorius AG, Merck KGaA, Danaher Corporation, Lonza Group AG, GE Healthcare, Waters Corporation, STADA Arzneimittel AG, Bio-Rad Laboratories Inc., Applikon Biotechnology B.V., Agilent Technologies Inc., Solida Biotech GmbH, Fujifilm Healthcare Corporation, Catalent Inc., Asahi Kasei Medical Inc., Amgen Inc., Eppendorf AG, Repligen Corporation, Becton dic*kinson and Company, MilliporeSigma, Novasep, Boehringer Ingelheim GmbH, Cytiva AB, Wuxi Biologics, AGC Biologics, Samsung Biologics, AbbVie Inc., Bristol Myers Squibb Company, Pfizer Inc., and Roche Holding AG.
A notable recent development includes Merck KGaA's acquisition of Mirus Bio for $600 million in August 2024. This strategic move aims to strengthen Merck's viral vector bioprocessing capabilities, offering more integrated manufacturing solutions from early-stage research to commercial production. Mirus Bio specializes in innovative gene delivery and life sciences research tools, making this acquisition valuable for expanding Merck's portfolio.

View the full bioprocessing technology market report:
https://www.thebusinessresearchcompany.com/report/bioprocessing-technology-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Feb_PR

Emerging Trends Shaping the Bioprocessing Technology Sector
Leading companies in the bioprocessing technology space are actively developing comprehensive bioprocessing platforms designed to enhance productivity and meet rising industry demands. These platforms combine a variety of techniques and technologies to optimize the large-scale production of biopharmaceuticals and other biological products.
For example, in October 2023, WuXi Biologics introduced WuXiUI, a cutting-edge bioprocessing platform that significantly boosts productivity and quality across multiple mammalian cell lines and product types. The platform uses an ultra-intensified intermittent-perfusion fed-batch (UI-IPFB) approach, achieving a 3 to 6 times increase in productivity compared to traditional fed-batch methods. This innovation addresses the growing need for improved yields, cost-effectiveness, and adherence to environmental, social, and governance (ESG) standards in bioprocess development.

Detailed Breakdown of Bioprocessing Technology Market Segments
The market is segmented based on product, application, and end-use categories.
By product types, the segments include biologics safety testing, cell culture, cell expansion, cell line development, flow cytometry, and tangential flow filtration.
Applications cover antibiotics, biosimilars, recombinant proteins, and other fields.
End users span biopharmaceutical companies, contract manufacturing organizations, academic research institutes, the food and feed industry, and contract research organizations.
Further subcategories involve specialized areas such as endotoxin, sterility, and viral safety testing within biologics safety; mammalian, microbial, and insect cell culture; manual versus automated cell expansion; hybridoma technology and recombinant cell line development; cell sorting and analysis in flow cytometry; and microfiltration and ultrafiltration under tangential flow filtration.

Regional Market Outlook and Growth Projections
North America currently holds the largest share of the bioprocessing technology market as of 2024. However, rapid growth is expected in regions such as Asia-Pacific due to increased investment in biopharmaceutical manufacturing infrastructure and expanding healthcare markets. This regional diversity highlights the global nature of the sector and its broad growth potential in the years ahead.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.